⌘K

Login Start Free

CYTOKINETICS INC·4

Jan 5, 4:26 PM ET

Callos Andrew 4

4 · CYTOKINETICS INC · Filed Jan 5, 2026

Insider Transaction Report

Form 4

Period: 2026-01-05

CYTOKINETICS INCCYTK

EVP, Chief Commercial Officer

Transactions

Exercise/Conversion
Common Stock
2026-01-05$23.26/sh+15,000$348,900→ 65,440 total
Sale
Common Stock
2026-01-05$60.28/sh−15,000$904,200→ 50,440 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2026-01-05−15,000→ 99,000 total
Exercise: $23.26From: 2022-03-31Exp: 2031-03-31→ Common Stock (15,000 underlying)

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT